Sylvain Lamure

Identifiants chercheurs

IdHAL :

sylvain-lamure

ORCID :

0000-0001-5980-305X

Présentation

Publications

Article dans une revue (35)

Large B-cell lymphoma: The LYSA pragmatic guidelines Pierre Sesques,Guillaume Manson,Sydney Dubois,Francois Xavier Gros,Gabriel Brisouet al. European Journal of Cancer, 2026, 232, pp.116070. ⟨10.1016/j.ejca.2025.116070⟩ Article dans une revue hal-05425271v1
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 Jon Salmanton-García,Francesco Marchesi,Francesca Farina,Barbora Weinbergerová,Federico Itriet al. EClinicalMedicine, 2024, 71, pp.102553. ⟨10.1016/j.eclinm.2024.102553⟩ Article dans une revue hal-04908727v1
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A Pedro Gonzalez-Menendez,Ira Phadke,Meagan Olive,Axel Joly,Julien Papoinet al. Blood, 2023, ⟨10.1182/blood.2022017584⟩ Article dans une revue hal-03986199v1
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion. Sophie Huby,Philippe Gelisse,Jean‐jacques Tudesq,Pierre Labauge,Claire Dufloset al. Neurology Neuroimmunology & Neuroinflammation, 2023, 10 (4), pp.e200111. ⟨10.1212/NXI.0000000000200111⟩ Article dans une revue hal-04071772v1
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey Jaap van Doesum,Jon Salmanton-García,Francesco Marchesi,Roberta Di Blasi,Iker Falces-Romeroet al. Blood Advances, 2023, 7 (11), pp.2645-2655. ⟨10.1182/bloodadvances.2022009578⟩ Article dans une revue hal-04911244v1
Anti‐PD ‐1 therapy can possibly reverse CAR T cells exhaustion in DLBCL Sylvain Lamure,Charles Herbaux British Journal of Haematology, 2023, 202 (2), pp.217-218. ⟨10.1111/bjh.18797⟩ Article dans une revue hal-04918596v1
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA) Maria Stefania Infante,Jon Salmanton-García,Ana Fernández-Cruz,Francesco Marchesi,Ozren Jaksicet al. Frontiers in Oncology, 2022, 12, ⟨10.3389/fonc.2022.992137⟩ Article dans une revue hal-04427149v1
Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution Pierre Rocanières,Sylvain Lamure,Christian Geny,Dominique Hillaire-Buys,Jean-Luc Faillieet al. Journal of Parkinson's disease, 2022, 12, pp.2601-2603. ⟨10.3233/JPD-223496⟩ Article dans une revue hal-04142920v1
Outcome of infection with omicron &lt;scp&gt;SARS‐CoV&lt;/scp&gt; ‐2 variant in patients with hematological malignancies: An &lt;scp&gt;EPICOVIDEHA&lt;/scp&gt; survey report Ola Blennow,Jon Salmanton-García,Piotr Nowak,Federico Itri,Jaap van Doesumet al. American Journal of Hematology, 2022, 97 (8), ⟨10.1002/ajh.26626⟩ Article dans une revue hal-03791162v1
Outcome of COVID-19 in Patients with Mantle Cell Lymphoma—Report from the European MCL Registry Marie Kristin Tilch,Carlo Visco,Sandra Bašić Kinda,Olivier Hermine,Milena Kohnet al. HemaSphere, 2022, 6 (5), pp.e0711. ⟨10.1097/HS9.0000000000000711⟩ Article dans une revue hal-03673380v1
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP Alessandro Busca,Jon Salmanton-García,Paolo Corradini,Francesco Marchesi,Alba Cabirtaet al. Blood Advances, 2022, 6 (7), pp.2427-2433. ⟨10.1182/bloodadvances.2021005616⟩ Article dans une revue hal-03645421v1
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis Thomas Hueso,Anne-Sophie Godron,Emilie Lanoy,Jérôme Pacanowski,Laura Leviet al. Leukemia, 2022, 36 (4), pp.1025-1034. ⟨10.1038/s41375-022-01511-6⟩ Article dans une revue hal-03642648v1
COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA) Francesco Marchesi,Jon Salmanton-García,Ziad Emarah,Klára Piukovics,Marcio Nucciet al. Haematologica, 2022, ⟨10.3324/haematol.2022.280847⟩ Article dans une revue hal-03791177v1
COVID-19 and Hairy-Cell Leukemia: An EPICOVIDEHA Survey Sylvain Lamure,Jon Salmanton-García,Elena Robin Marieton,Ozren Jaksic,Milena Kohnet al. Blood Advances, 2022, 6 (13), pp.3870-3874. ⟨10.1182/bloodadvances.2022007357⟩ Article dans une revue hal-03690034v1
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey Livio Pagano,Jon Salmanton-García,Francesco Marchesi,Ola Blennow,Maria Gomes da Silvaet al. Blood, 2022, ⟨10.1182/blood.2022017257/1922289/blood.2022017257.pdf⟩ Article dans une revue hal-03791153v1
Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak Milena Kohn,Tamim Alsuliman,Sylvain Lamure,Morgane Cheminant,Jéremy Delageet al. Leukemia & lymphoma, 2022, pp.1-5. ⟨10.1080/10428194.2022.2086249⟩ Article dans une revue hal-03791160v1
COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA Livio Pagano,Jon Salmanton-García,Francesco Marchesi,Alberto López-García,Sylvain Lamureet al. Blood, 2022, 139 (10), pp.1588-1592. ⟨10.1182/blood.2021014124⟩ Article dans une revue hal-03791235v1
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Livio Pagano,Jon Salmanton-García,Francesco Marchesi,Alessandro Busca,Paolo Corradiniet al. Journal of Hematology and Oncology, 2021, 14 (1), pp.168. ⟨10.1186/s13045-021-01177-0⟩ Article dans une revue hal-03642030v1
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy Sylvain Lamure,François van Laethem,Delphine de Verbizier,Claire Lozano,Eve Gehlkopfet al. Cancers, 2021, 13 (17), pp.4279. ⟨10.3390/cancers13174279⟩ Article dans une revue hal-03327590v1
Nouvelle AMM : duvelisib – LLC et lymphome folliculaire en rechute ou réfractaire Léa Fornero,Sylvain Lamure Bulletin du Cancer, 2021, 108 (10), pp.906-907. ⟨10.1016/j.bulcan.2021.06.010⟩ Article dans une revue hal-03791143v1
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy Rémy Duléry,Sylvain Lamure,Marc Delord,Roberta Di Blasi,Adrien Chauchetet al. American Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩ Article dans une revue hal-03401859v1
Immunomonitoring du rituximab appliqué aux maladies auto-immunes : une aide pour la pratique clinique ? Megane Giraud,Pascal Cathébras,X. Roblin,Damien Thibaudin,Sylvain Lamureet al. La Revue de Médecine Interne, 2021, 42 (6), pp.384-391. ⟨10.1016/j.revmed.2021.02.006⟩ Article dans une revue hal-03203418v1
COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP Alessandro Busca,Jon Salmanton-García,Paolo Corradini,Francesco Marchesi,Alba Cabirtaet al. Blood Advances, 2021, ⟨10.1182/bloodadvances.2021005616/1833925/bloodadvances.2021005616.pdf⟩ Article dans une revue hal-03430350v1
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database Radjiv Goulabchand,Nicolas Malafaye,William Jacot,Philine Witkowski Durand Viel,Jacques Morelet al. Autoimmunity Reviews, 2021, 20 (12), pp.102987. ⟨10.1016/j.autrev.2021.102987⟩ Article dans une revue hal-03622565v1
The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study Orianne Villard,David Morquin,Nicolas Molinari,Isabelle Raingeard,Nicolas Nagotet al. Journal of Clinical Medicine, 2020, 9 (7), pp.2315. ⟨10.3390/jcm9072315⟩ Article dans une revue hal-02906692v1
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment Sylvain Lamure,Franciane Paul,Anne-Laure Gagez,Jérémy Delage,Laure Vincentet al. Journal of Clinical Medicine, 2020, 9 (7), pp.2204. ⟨10.3390/jcm9072204⟩ Article dans une revue hal-03203259v1
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study Sylvain Lamure,Rémy Duléry,Roberta Di Blasi,Adrien Chauchet,Cécile Laureanaet al. EClinicalMedicine, 2020, 27, pp.100549. ⟨10.1016/j.eclinm.2020.100549⟩ Article dans une revue hal-03203358v1
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases Guillaume Aussedat,Alexandra Traverse‐glehen,Aspasia Stamatoullas,Thierry Molina,Violaine Safaret al. British Journal of Haematology, 2020, 189 (2), pp.244-256. ⟨10.1111/bjh.16331⟩ Article dans une revue hal-02872482v1
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy Catherine Belin,Perrine Devic,Xavier Ayrignac,Amélie dos Santos,Adrien Paixet al. Scientific Reports, 2020, 10 (1), pp.91-93. ⟨10.1038/s41598-020-76055-9⟩ Article dans une revue hal-03203401v1
Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells Claire Gourzones,Céline Bellanger,Sylvain Lamure,Ouissem Karmous Gadacha,Elvira Garcia de Pacoet al. Cancers, 2019, 11 (4), pp.439. ⟨10.3390/cancers11040439⟩ Article dans une revue hal-02870153v1
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma Sylvain Lamure,Camille Carles,Quam Aquereburu,Philippe Quittet,Emmanuelle Tchernonoget al. JAMA Network Open, 2019, 2 (4), pp.e192093. ⟨10.1001/jamanetworkopen.2019.2093⟩ Article dans une revue hal-02863305v1
Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) John de Vos,Etienne Baudoux,Jacques-Olivier Bay,Boris Calmels,Audrey Craset al. Bulletin du Cancer, 2019, 106 (1), pp.S35-S39 Article dans une revue hal-02055937v1
Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) John de Vos,Etienne Baudoux,Jacques-Olivier Bay,Boris Calmels,Audrey Craset al. Bulletin du Cancer, 2019, 106 (1), pp.S35-S39. ⟨10.1016/j.bulcan.2018.10.002⟩ Article dans une revue hal-02650987v1
Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease? S. Lamure,J. Delage,L. Vincent,N. Fegueux,L. Zhao-Yanget al. Current Research in Translational Medicine, 2018, 66 (3), pp.91-93. ⟨10.1016/j.retram.2018.02.003⟩ Article dans une revue hal-03122708v1
Transfusion thérapeutique de granulocytes : cinétique et aspects organisationnels autour d’un cas clinique Sylvain Lamure,P. Latry,T. Kanouni,Y. Hicheri,L Vincentet al. Transfusion Clinique et Biologique, 2014, 21 (6), pp.324 - 327. ⟨10.1016/j.tracli.2014.09.005⟩ Article dans une revue hal-03203379v1

Poster de conférence (1)

Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression Benoît Tisserand,Caroline Bret,Yassine Al Tabaa,Sylvain Lamure,Xavier Ayrignacet al. 65th ASH Annual Meeting (ASH 2023), Dec 2023, San Diego (CA), United States. Elsevier, Blood, 142 (Supplement 1), pp.3124-3125, 2023, The 65th ASH Annual Meeting Abstracts. ⟨10.1182/blood-2023-185520⟩ Poster de conférence hal-05474613v1